1. Home
  2. EQBK vs FTRE Comparison

EQBK vs FTRE Comparison

Compare EQBK & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EQBK
  • FTRE
  • Stock Information
  • Founded
  • EQBK 2002
  • FTRE 1996
  • Country
  • EQBK United States
  • FTRE United States
  • Employees
  • EQBK N/A
  • FTRE N/A
  • Industry
  • EQBK Major Banks
  • FTRE Medical Specialities
  • Sector
  • EQBK Finance
  • FTRE Health Care
  • Exchange
  • EQBK Nasdaq
  • FTRE Nasdaq
  • Market Cap
  • EQBK 800.2M
  • FTRE 864.4M
  • IPO Year
  • EQBK 2015
  • FTRE N/A
  • Fundamental
  • Price
  • EQBK $40.51
  • FTRE $10.46
  • Analyst Decision
  • EQBK Buy
  • FTRE Hold
  • Analyst Count
  • EQBK 6
  • FTRE 9
  • Target Price
  • EQBK $47.80
  • FTRE $13.06
  • AVG Volume (30 Days)
  • EQBK 109.2K
  • FTRE 1.0M
  • Earning Date
  • EQBK 10-14-2025
  • FTRE 11-05-2025
  • Dividend Yield
  • EQBK 1.78%
  • FTRE N/A
  • EPS Growth
  • EQBK N/A
  • FTRE N/A
  • EPS
  • EQBK 1.00
  • FTRE N/A
  • Revenue
  • EQBK $186,307,000.00
  • FTRE $2,733,500,000.00
  • Revenue This Year
  • EQBK $12.71
  • FTRE N/A
  • Revenue Next Year
  • EQBK $41.13
  • FTRE N/A
  • P/E Ratio
  • EQBK $40.37
  • FTRE N/A
  • Revenue Growth
  • EQBK 18.09
  • FTRE N/A
  • 52 Week Low
  • EQBK $34.11
  • FTRE $3.97
  • 52 Week High
  • EQBK $50.85
  • FTRE $25.28
  • Technical
  • Relative Strength Index (RSI)
  • EQBK 47.18
  • FTRE 54.73
  • Support Level
  • EQBK $40.15
  • FTRE $10.25
  • Resistance Level
  • EQBK $42.34
  • FTRE $10.91
  • Average True Range (ATR)
  • EQBK 1.40
  • FTRE 0.61
  • MACD
  • EQBK 0.00
  • FTRE -0.03
  • Stochastic Oscillator
  • EQBK 49.29
  • FTRE 55.87

About EQBK Equity Bancshares Inc.

Equity Bancshares Inc is a bank holding company. It provides a broad range of financial services to businesses and business owners as well as individuals through network of nearly 71 branches located in Arkansas, Kansas, Missouri and Oklahoma. The majority of the Company's revenues come from interest income on financial instruments, including loans, leases, securities and derivatives. The company also earns revenue from Non-interest income which includes Service charges and fees, Debit card income, Investment Referral Income, Trust Income and Insurance Sales Commissions.

About FTRE Fortrea Holdings Inc.

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Share on Social Networks: